Form 8-K - Current report:
SEC Accession No. 0000950170-23-055626
Filing Date
2023-10-26
Accepted
2023-10-26 16:20:58
Documents
16
Period of Report
2023-10-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cc-20231026.htm   iXBRL 8-K 50007
2 EX-99.1 cc-ex99_1.htm EX-99.1 1386353
3 GRAPHIC img15408389_0.jpg GRAPHIC 37595
4 GRAPHIC img15408389_1.jpg GRAPHIC 26020
5 GRAPHIC img171786479_0.jpg GRAPHIC 35795
  Complete submission text file 0000950170-23-055626.txt   1791782

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cc-20231026_lab.xml EX-101.LAB 17020
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cc-20231026_pre.xml EX-101.PRE 10671
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cc-20231026.xsd EX-101.SCH 2468
10 EXTRACTED XBRL INSTANCE DOCUMENT cc-20231026_htm.xml XML 4507
Mailing Address 1007 MARKET STREET WILMINGTON DE 19801
Business Address 1007 MARKET STREET WILMINGTON DE 19801 302 773 1000
Chemours Co (Filer) CIK: 0001627223 (see all company filings)

EIN.: 464845564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36794 | Film No.: 231350446
SIC: 2800 Chemicals & Allied Products